Jeffrey S. Morris

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	29075	11648
h-endeksi	83	45
i10-endeksi	233	169

2500

1250

625

1875

20032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025118 291 620 753 835 900 1007 1110 1052 1078 1060 1009 1111 1289 1485 1614 1673 1975 2466 2257 2212 2265 463

Genel erişim

Tümünü görüntüle

153 makale

8 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Scott KopetzUniversity of Texas MD Anderson Cancer Centermdanderson.org üzerinde doğrulanmış e-posta adresine sahip
Kevin CoombesProfessor of Population Health Sciences, Georgia Cancer Center at Augusta Universityaugusta.edu üzerinde doğrulanmış e-posta adresine sahip
Veera BaladandayuthapaniProfessor, Biostatistics, University of Michiganumich.edu üzerinde doğrulanmış e-posta adresine sahip
Ganiraju ManyamPrincipal BioAnalyst, Department of Bioinformatics & Computational Biology, The UT MD Andersonmdanderson.org üzerinde doğrulanmış e-posta adresine sahip
Reham Abdel-WahabAssistant Professor at MD Anderson Cancer Center, Associate Professor at Assiut faculty of medicinemdanderson.org üzerinde doğrulanmış e-posta adresine sahip
Zhiqin Jiang (Zhi-Qin Jiang, MD, PhD)The University of Texas MD Anderson Cancer Centermdanderson.org üzerinde doğrulanmış e-posta adresine sahip
Donghui LiUT MD Anderson Cancer Centermdanderson.org üzerinde doğrulanmış e-posta adresine sahip
Robert ChapkinDistinguished Professor of Nutrition, Texas A&M Universitytamu.edu üzerinde doğrulanmış e-posta adresine sahip
Jack RothProfessor of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Centermdanderson.org üzerinde doğrulanmış e-posta adresine sahip
Funda Meric-BernstamChair, Department of Investigational Cancer Therapeutics, The UT MD Anderson Cancer Centermdanderson.org üzerinde doğrulanmış e-posta adresine sahip
John HeymachChair, Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Centermdanderson.org üzerinde doğrulanmış e-posta adresine sahip
Paulo M. HoffProfessor de Oncologia, Faculdade de Medicina, Universidade de Sao Pauloicesp.org.br üzerinde doğrulanmış e-posta adresine sahip
Bradley BroomUT MD Anderson Cancer Centermdanderson.org üzerinde doğrulanmış e-posta adresine sahip
N. Arvind DasariUniversity of Texas MD Anderson Cancer Centermdanderson.org üzerinde doğrulanmış e-posta adresine sahip
Jean-Pierre IssaCoriell Institute for Medical Researchcoriell.org üzerinde doğrulanmış e-posta adresine sahip
Christopher LieuUNIVERSITY OF COLORADOcuanschutz.edu üzerinde doğrulanmış e-posta adresine sahip
J. Crawford DownsProfessor of Ophthalmology and Visual Sciences, UABuab.edu üzerinde doğrulanmış e-posta adresine sahip
Simon LunagomezVisiting Professor at ITAMitam.mx üzerinde doğrulanmış e-posta adresine sahip
Chris GirkinUniversity of Alabama at Birminghamuabmc.edu üzerinde doğrulanmış e-posta adresine sahip
Nancy TurnerTexas A&M Universitytamu.edu üzerinde doğrulanmış e-posta adresine sahip

Takip et

Jeffrey S. Morris

University of Pennsylvania

pennmedicine.upenn.edu üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa

Data Science Statistics Biostatistics Bioinformatics Big Data


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
The consensus molecular subtypes of colorectal cancer J Guinney, R Dienstmann, X Wang, A De Reynies, A Schlicker, ... Nature medicine 21 (11), 1350-1356, 2015	5100	2015
Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments KA Baggerly, JS Morris, KR Coombes Bioinformatics 20 (5), 777-785, 2004	813	2004
Functional regression JS Morris Annual Review of Statistics and Its Application 2 (1), 321-359, 2015	593	2015
Body mass index and risk, age of onset, and survival in patients with pancreatic cancer D Li, JS Morris, J Liu, MM Hassan, RS Day, ML Bondy, JL Abbruzzese Jama 301 (24), 2553-2562, 2009	589	2009
Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with … S Kopetz, PM Hoff, JS Morris, RA Wolff, C Eng, KY Glover, R Adinin, ... Journal of clinical oncology 28 (3), 453-459, 2010	549	2010
Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation LR Chirieac, SG Swisher, JA Ajani, RR Komaki, AM Correa, JS Morris, ... Cancer 103 (7), 1347-1355, 2005	532	2005
Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma JA Ajani, PF Mansfield, N Janjan, J Morris, PW Pisters, PM Lynch, B Feig, ... Journal of clinical oncology 22 (14), 2774-2780, 2004	522	2004
Wavelet-based functional mixed models JS Morris, RJ Carroll Journal of the Royal Statistical Society Series B: Statistical Methodology …, 2006	512	2006
Cutaneous angiosarcoma of the scalp: a multidisciplinary approach TM Pawlik, AF Paulino, CJ Mcginn, LH Baker, DS Cohen, JS Morris, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2003	442	2003
Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients TM Pawlik, F Izzo, DS Cohen, JS Morris, SA Curley Annals of surgical oncology 10, 1059-1069, 2003	440	2003
Feature extraction and quantification for mass spectrometry in biomedical applications using the mean spectrum JS Morris, KR Coombes, J Koomen, KA Baggerly, R Kobayashi Bioinformatics 21 (9), 1764-1775, 2005	428	2005
Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma MB Thomas, R Chadha, K Glover, X Wang, J Morris, T Brown, A Rashid, ... Cancer 110 (5), 1059-1067, 2007	422	2007
Improved peak detection and quantification of mass spectrometry data acquired from surface‐enhanced laser desorption and ionization by denoising spectra with the undecimated … KR Coombes, S Tsavachidis, JS Morris, KA Baggerly, MC Hung, ... Proteomics 5 (16), 4107-4117, 2005	418	2005
Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma MB Thomas, JS Morris, R Chadha, M Iwasaki, H Kaur, E Lin, A Kaseb, ... Journal of Clinical Oncology 27 (6), 843-850, 2009	400	2009
Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer KA Baggerly, JS Morris, SR Edmonson, KR Coombes Journal of the National Cancer Institute 97 (4), 307-309, 2005	390	2005
Differential expression in SAGE: accounting for normal between-library variation KA Baggerly, L Deng, JS Morris, CM Aldaz Bioinformatics 19 (12), 1477-1483, 2003	387	2003
Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome JA Ajani, PF Mansfield, CH Crane, TT Wu, S Lunagomez, PM Lynch, ... Journal of clinical oncology 23 (6), 1237-1244, 2005	361	2005
Classifying colorectal cancer by tumor location rather than sidedness highlights a continuum in mutation profiles and consensus molecular subtypes JM Loree, AAL Pereira, M Lam, AN Willauer, K Raghav, A Dasari, ... Clinical Cancer Research 24 (5), 1062-1072, 2018	353	2018
Clinical and molecular characterization of early‐onset colorectal cancer AN Willauer, Y Liu, AAL Pereira, M Lam, JS Morris, KPS Raghav, ... Cancer 125 (12), 2002-2010, 2019	335	2019
The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-δ to induce apoptosis in colorectal cancer cells I Shureiqi, W Jiang, X Zuo, Y Wu, JB Stimmel, LM Leesnitzer, JS Morris, ... Proceedings of the National Academy of Sciences 100 (17), 9968-9973, 2003	300	2003

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar